Why is "Hoffmann-La Roche" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-31 02:10:09
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Hoffmann-La_Roche entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-31 and was most recently seen on 2026-03-31.
Wikipedia Overview
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
Related Topics
Trending Topic Today
Search Interest Perspective
-
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States - Yahoo Finance
-
Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for Perjeta® (pertuzumab) for the neoadjuvant treatment of aggressive early stage breast cancer - PR Newswire Canada
-
Hoffmann-La Roche lands PI against Menarini Diagnostics from UPC - JUVE Patent
-
Roche presents new data in Alzheimer’s disease from across - GlobeNewswire
-
Roche KRAS drug succeeds in head-to-head lung cancer study - BioPharma Dive
-
Biotech Giant Roche To Triple Investment Footprint on Harvard’s Enterprise Research Campus - The Harvard Crimson
-
Roche’s Annual Report 2025 - Roche
-
Dario Lombardini, Organizational Change Management Specialist, F. Hoffmann-La Roche - Università della Svizzera italiana | USI
-
China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Reuters
-
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer - GlobeNewswire
-
Delhi High Court’s Ruling in F. Hoffmann-La Roche Ag & Anr. V. Natco Pharma - Cyril Amarchand Mangaldas
-
News | Reimagining of Ex-Hoffmann-La Roche Campus Enters Next Stage With Anchor Office Tenant Eisai - CoStar
-
Roche receives CE Mark for blood test to identify tuberculosis infection - Yahoo Finance UK
-
Hoffmann-La Roche to Close Nutley Plant, Cut Jobs - NJ Spotlight News
-
Life After Hoffmann-La Roche: ON3 In Nutley, Clifton Gets More Awards - Patch
-
Hoffmann-La Roche Whistleblower Drops Tamiflu Fraud Suit (2) - Bloomberg Law News
-
Q&A with Hoffmann-La Roche’s Rana Kassab - Benefits Canada.com
-
More Growth At Ex-Hoffmann-La Roche Site In Nutley, Clifton - Patch
-
News | Japanese Pharma Firm Leases Former Hoffmann-La Roche Office Tower - CoStar
-
News | Prism Capital Relocates Headquarters to Former Hoffmann-La Roche Site - CoStar
-
F Hoffmann La Roche Ltd - Reuters
-
Former Hoffmann-La Roche Site In Nutley Sold: N.J. Developer Closes Deal - Patch
-
MOMA Therapeutics and Roche sign cancer drug discovery deal - Pharmaceutical Technology
-
Transformation of Former Pharmaceutical Complex in Nutley and Clifton Continues - Jersey Digs
-
Diagnostics in oncology - Roche
-
Avastin (bevacizumab) - Roche
-
Nutley Meeting On Former Hoffmann-La Roche Site: What’s Next? - Patch
-
Roche Holding - Forbes
-
France/Switzerland • Maja Hoffmann, the patron of the arts who brought the luxury world to Arles - 14/12/2023 - Glitz
-
Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche - PR Newswire
-
Roche targets continued growth after strong 2024 sales - Pharmaceutical Technology
-
The $1.3 billion share sale that has rocked one of the world’s richest families - SMH.com.au
-
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma - PR Newswire
-
Five-star luxury hotel, conference center eyes former Hoffmann-La Roche site - Bergen Record
-
Alfred Pletscher - Nature
-
Roche to acquire biopharma firm Good Therapeutics for $250m - Pharmaceutical Technology
-
Cancer drug Herceptin: setbacks for Hoffmann-La Roche - JUVE Patent
-
Japan-based pharmaceutical company to bring 1,200 employees to former Hoffmann-La Roche site - Bergen Record
-
The generation game: the women behind the Emanuel Hoffmann Foundation - The Art Newspaper
-
ON3 Campus Office Tower in Nutley Sells for $132 Million - Jersey Digs
-
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston - Yahoo Finance UK
-
GEORGE TEABO Obituary (2018) - Washington, NJ - LehighValleyLive.com
-
Clever delivery - Roche
-
Nutley, Developer Continue Shoving Match Over 'ON3' Complex - Patch
-
Switzerland’s Biggest Family Fortune Has Prospered for 124 Years - Bloomberg
-
Neurology Market Research Overview 2025, Profiles of Major Players - F. Hoffmann-La Roche, Novartis, UCB, and Otsuka - ResearchAndMarkets.com - Business Wire
-
Austria continues to play steady role in European patent litigation - JUVE Patent
-
Robert Sunbury Obituary (1943 - 2019) - Newark, NJ - NJ.com
-
Roche's Annual Report 2022 - Roche
-
Power Plant Upgrades Planned At ON3 Complex In Nutley, Clifton - Patch
-
Saudi pharma sector takes leap forward with Hoffmann La Roche localization deal - Arab News
-
This Day in Jewish History • 2005: Death of chemist who discovered Valium - Haaretz
-
Video: Timeline for Roche campus' redevelopment - Bergen Record
-
Ex-Roche Site Booming In Nutley: Med School, Ralph Lauren - Patch
-
A $900 Million Share Sale Tests One of World’s Richest Families - Bloomberg
-
Roche will close Nutley plant, shed nearly 1,000 jobs - NJ.com
-
Hoffmann-Oeri Family - Tharawat Magazine
-
New Hackensack Meridian Urgent Care Now Open On Rt. 3 - Patch
-
Non-Invasive Prenatal Testing Market Forecast and Company - GlobeNewswire
-
Hoffman La Roche Biotechnology Plant Expansion, Penzberg, Upper Bavaria - Pharmaceutical Technology
-
From the archives: In hunt for killer, police will revisit a 1968 mystery (2005) - NJ.com
-
In NJ Incident, Police Confuse Followers of Lyndon LaRouche With Workers for Drug Giant La Roche - Talking Points Memo
-
Roche descendant André Hoffmann on pharma, feuds and family business - SWI swissinfo.ch
-
Hackensack Meridian will pick up whole cost for new medical school - Bergen Record
-
In Progress: Roche Building 1 / Herzog & de Meuron - ArchDaily
-
New Quest Diagnostics lab to open at former Hoffman-La Roche site in Clifton - Bergen Record
-
Roche Canada announces Polivy® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma is now Publicly Reimbursed in Québec - PR Newswire Canada
-
Suicide Pilot's Mom Blames Accutane - CBS News
-
HEART DRUG WITHDRAWN - The Washington Post
-
F. Hoffmann-La Roche AG shows interest in cooperation with Belarus - Belarus.by
-
Sterling Drug Inc. agreed Friday to be acquired by... - upi.com
-
Saridon survives and surges - History of Saridon - ET HealthWorld
-
Toward a Sobriety Pill - The Washington Post
-
Quest Diagnostics project taking shape in Clifton - Bergen Record
-
IN NUTLEY, GUESSES ON LAYOFFS BEGIN (Published 1985) - The New York Times
-
Roche Canada expands global informatics hub in Ontario - Invest Ontario
-
Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet - The Economic Times
-
Dr. Virginius Mattia, 48, Dies; Hoffmann‐La Roche President (Published 1971) - The New York Times
-
Roche shareholders' pool: Inclusion of the fifth generation completed - Presseportal.ch
-
Valium Ads: Sales Pitch Or Product Information? - The Washington Post
-
Remembering whistleblower Stanley Adams - 'a proud man' who stood up for his beliefs - Dorset Echo
-
Bilirubin Blood Test Market Is Booming So Rapidly | F. - openPR.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.